<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Andrew J. Sims" />


<title>Markov Model with PSA (Chancellor 1997 revisited)</title>

<script src="data:application/javascript;base64,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"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>


<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">
/* for pandoc --citeproc since 2.11 */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="data:text/css,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Markov Model with PSA (Chancellor 1997 revisited)</h1>
<h3 class="subtitle">Monotherapy versus combination therapy for HIV</h3>
<h4 class="author">Andrew J. Sims</h4>
<h4 class="date">July 2021</h4>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>This vignette is an example of an elementary cohort Markov model using the <code>rdecision</code> package. It is based on the example given by Briggs <em>et al</em><span class="citation"><sup>1</sup></span> (Exercise 2.5) which itself is based on a Markov model described by Chancellor <em>et al</em>.<span class="citation"><sup>2</sup></span> The model compares a combination therapy of Lamivudine/Zidovudine versus Zidovudine monotherapy in people with HIV infection.</p>
</div>
<div id="creating-the-model" class="section level1">
<h1>Creating the model</h1>
<p>The variables used in the model are all numerical constants, and are defined as follows. The original model was based on annual transition probabilities; these are converted to instantaneous hazard rates in units of events/year.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co"># transition rates calculated from annual transition probabilities</span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a>trAB <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.202</span>)<span class="sc">/</span><span class="dv">1</span> </span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a>trAC <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.067</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a>trAD <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.010</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a>trBC <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.407</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a>trBD <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.012</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a>trCD <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.250</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a><span class="co"># Costs</span></span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a>dmca <span class="ot">&lt;-</span> <span class="dv">1701</span> <span class="co"># direct medical costs associated with state A</span></span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a>dmcb <span class="ot">&lt;-</span> <span class="dv">1774</span> <span class="co"># direct medical costs associated with state B</span></span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>dmcc <span class="ot">&lt;-</span> <span class="dv">6948</span> <span class="co"># direct medical costs associated with state C</span></span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a>ccca <span class="ot">&lt;-</span> <span class="dv">1055</span> <span class="co"># Community care costs associated with state A</span></span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a>cccb <span class="ot">&lt;-</span> <span class="dv">1278</span> <span class="co"># Community care costs associated with state B</span></span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a>cccc <span class="ot">&lt;-</span> <span class="dv">2059</span> <span class="co"># Community care costs associated with state C</span></span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a><span class="co"># Drug costs</span></span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a>cAZT <span class="ot">&lt;-</span> <span class="dv">2278</span> <span class="co"># zidovudine drug cost</span></span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a>cLam <span class="ot">&lt;-</span> <span class="dv">2087</span> <span class="co"># lamivudine drug cost</span></span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a><span class="co"># Other parameters</span></span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a>RR <span class="ot">&lt;-</span> <span class="fl">0.509</span> <span class="co"># treatment effect</span></span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a>cDR <span class="ot">&lt;-</span> <span class="dv">6</span> <span class="co"># annual discount rate, costs (%)</span></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a>oDR <span class="ot">&lt;-</span> <span class="dv">0</span> <span class="co"># annual discount rate, benefits (%)</span></span></code></pre></div>
<p>The model is constructed by forming a graph, with each state as a node and each transition as an edge. Nodes (of class <code>MarkovState</code>) and edges (class <code>MarkovTransition</code>) have various properties whose values reflect the variables of the model (costs, rates etc.). The rate for one of the outgoing transitions from each non-absorbing state is set to NULL to allow the sum of probabilities leaving each state, per cycle, to be adjusted to 1 within the package. The usual case, as here, is to set the self-loop rates to NULL and the package will compute the probability of remaining in a state as one minus the probability of leaving the state. Because the model is intended to evaluate survival, the utility of states A, B and C are set to 1 (by default) and state D to zero. Thus the incremental quality adjusted life years gained per cycle is equivalent to the survival function.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a><span class="co"># create Markov states for monotherapy (zidovudine only)</span></span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a>sA <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;A&quot;</span>, <span class="at">cost=</span>dmca<span class="sc">+</span>ccca<span class="sc">+</span>cAZT)</span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a>sB <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;B&quot;</span>, <span class="at">cost=</span>dmcb<span class="sc">+</span>cccb<span class="sc">+</span>cAZT)</span>
<span id="cb2-4"><a href="#cb2-4" aria-hidden="true" tabindex="-1"></a>sC <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;C&quot;</span>, <span class="at">cost=</span>dmcc<span class="sc">+</span>cccc<span class="sc">+</span>cAZT)</span>
<span id="cb2-5"><a href="#cb2-5" aria-hidden="true" tabindex="-1"></a>sD <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;D&quot;</span>, <span class="at">cost=</span><span class="dv">0</span>, <span class="at">utility=</span><span class="dv">0</span>)</span>
<span id="cb2-6"><a href="#cb2-6" aria-hidden="true" tabindex="-1"></a><span class="co"># create transitions</span></span>
<span id="cb2-7"><a href="#cb2-7" aria-hidden="true" tabindex="-1"></a>tAA <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sA, sA, <span class="at">r=</span><span class="cn">NULL</span>)</span>
<span id="cb2-8"><a href="#cb2-8" aria-hidden="true" tabindex="-1"></a>tAB <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sA, sB, <span class="at">r=</span>trAB)</span>
<span id="cb2-9"><a href="#cb2-9" aria-hidden="true" tabindex="-1"></a>tAC <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sA, sC, <span class="at">r=</span>trAC)</span>
<span id="cb2-10"><a href="#cb2-10" aria-hidden="true" tabindex="-1"></a>tAD <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sA, sD, <span class="at">r=</span>trAD)</span>
<span id="cb2-11"><a href="#cb2-11" aria-hidden="true" tabindex="-1"></a>tBB <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sB, sB, <span class="at">r=</span><span class="cn">NULL</span>)</span>
<span id="cb2-12"><a href="#cb2-12" aria-hidden="true" tabindex="-1"></a>tBC <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sB, sC, <span class="at">r=</span>trBC)</span>
<span id="cb2-13"><a href="#cb2-13" aria-hidden="true" tabindex="-1"></a>tBD <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sB, sD, <span class="at">r=</span>trBD)</span>
<span id="cb2-14"><a href="#cb2-14" aria-hidden="true" tabindex="-1"></a>tCC <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sC, sC, <span class="at">r=</span><span class="cn">NULL</span>)</span>
<span id="cb2-15"><a href="#cb2-15" aria-hidden="true" tabindex="-1"></a>tCD <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sC, sD, <span class="at">r=</span>trCD)</span>
<span id="cb2-16"><a href="#cb2-16" aria-hidden="true" tabindex="-1"></a>tDD <span class="ot">&lt;-</span> MarkovTransition<span class="sc">$</span><span class="fu">new</span>(sD, sD, <span class="at">r=</span><span class="cn">NULL</span>)</span>
<span id="cb2-17"><a href="#cb2-17" aria-hidden="true" tabindex="-1"></a><span class="co"># construct the model</span></span>
<span id="cb2-18"><a href="#cb2-18" aria-hidden="true" tabindex="-1"></a>mhiv <span class="ot">&lt;-</span> CohortMarkovModel<span class="sc">$</span><span class="fu">new</span>(</span>
<span id="cb2-19"><a href="#cb2-19" aria-hidden="true" tabindex="-1"></a>  <span class="at">V =</span> <span class="fu">list</span>(sA, sB, sC, sD),</span>
<span id="cb2-20"><a href="#cb2-20" aria-hidden="true" tabindex="-1"></a>  <span class="at">E =</span> <span class="fu">list</span>(tAA, tAB, tAC, tAD, tBB, tBC, tBD, tCC, tCD, tDD),</span>
<span id="cb2-21"><a href="#cb2-21" aria-hidden="true" tabindex="-1"></a>  <span class="at">hcc =</span> <span class="cn">FALSE</span>,</span>
<span id="cb2-22"><a href="#cb2-22" aria-hidden="true" tabindex="-1"></a>  <span class="at">discount.cost =</span> cDR<span class="sc">/</span><span class="dv">100</span>,</span>
<span id="cb2-23"><a href="#cb2-23" aria-hidden="true" tabindex="-1"></a>  <span class="at">discount.utility =</span> oDR<span class="sc">/</span><span class="dv">100</span></span>
<span id="cb2-24"><a href="#cb2-24" aria-hidden="true" tabindex="-1"></a>)</span></code></pre></div>
</div>
<div id="checking-the-model" class="section level1">
<h1>Checking the model</h1>
<div id="diagram" class="section level2">
<h2>Diagram</h2>
<p>A representation of the model in DOT format (<a href="https://graphviz.org">Graphviz</a>) can be created using the <code>as_DOT</code> function of <code>CohortMarkovModel</code>. The function returns a character vector which can be saved in a file (<code>.gv</code> extension) for visualization with the <code>dot</code> tool of Graphviz, or plotted directly in R via the <code>DiagrammeR</code> package. The Markov model for monotherapy is shown in Figure 1.</p>
<div class="figure" style="text-align: center">
<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAbsAAACdCAYAAAAt69aBAAAABmJLR0QA/wD/AP+gvaeTAAAgAElEQVR4nOzdd1wU1/o/8M8WYGlSpEqz0IsKBERAwRITC8So3JiCPV5Nbmz3GmLXJCpq/NoTNRqDmmgkxkRju0FFEAsoWBAVC12aSO+7+/z+8MdeCUWEZWeB83699uWwMzvnGY7sM3PmzDk8IiIwDMMwTOcVzuc6AoZhGIZpbyzZMQzDMJ0eS3YMwzBMpyfkOgCGYTqP2tpapKamori4GEVFRaiqqkJVVRV0dXWhq6sLHR0d6OjoQF9fH0Ih+/phFIf9b2MYplXEYjGuX7+OyMhIXLp0CQ8ePEBqairEYvErP6uqqgo7Ozu4uLjA19cXQ4YMgb29vQKiZroqHuuNyTDM64iNjcUPP/yAw4cPo7i4GKampvD394eTkxOsra1hY2MDXV1d6OnpQSQSQU1NTXalV1xcjOLiYmRkZCApKQkJCQmIiYlBaWkp7O3tMXHiRHz88cfo0aMH14fJdC7hLNkxDNMi586dw+LFixEbGwsnJydMmzYNo0ePhp2dXZv2K5FIcPnyZRw7dgw//fQTnj9/jg8//BDLly9H79695RQ908WxZMcwTPMyMzPx8ccf48yZMxg5ciSWL18OLy+vdimruroav/zyC77++mukp6dj0aJFWLRoEVRVVdulPKbLYMmOYZimHT9+HNOmTYORkRG+++47+Pn5KaRcsViMrVu3Yvny5XB0dER4eDisrKwUUjbTKbGHyhmGadzOnTsxduxYvPvuu7h+/brCEh0ACIVCLFiwAPHx8aisrISXlxdu376tsPKZzoclO4ZhGtixYwc++eQTrF69Gt9//z00NDQ4icPW1haXL1+Gg4MDhg4digcPHnASB9PxsWZMhmHquXjxIoYPH44vv/wSixYt4jocAEBlZSWGDh2K/Px83LhxAzo6OlyHxHQs7J4dwzD/U1BQABcXF3h7eyM8PBw8Ho/rkGTy8vLQr18/DB8+HAcOHOA6HKZjYffsGIb5ny+//BJEhL179ypVogMAIyMj7NmzBwcPHkRkZCTX4TAdDLuyYxgGAPD48WM4ODhg+/btmDlzJtfhNGnUqFEoKirC5cuXuQ6F6TjYlR3DMC/s3r0bPXr0wPTp07kOpVmLFy/GlStXEBsby3UoTAfCkh3DMJBIJDh48CAmTZoEgUDAdTjN8vX1hY2NDY4dO8Z1KEwHwpIdwzCIj4/H06dP8d5773EdSqO+/fZbhIeHIyEhAaWlpRg1ahROnz7NdVhMB8JmPWAYBleuXIG+vj4cHR25DqVRv/76Ky5cuCD7WVtbG9XV1fjoo4/g6OgIa2tr2SDU2traHEbKKCuW7BiGQXx8PDw8PJSuB2YdDw8PxMTEoKamBgBQWloKAPjll18gEAhQU1MDIkKPHj3w5MkTqKmpcRkuo4RYsmMYBtnZ2bCwsOA6jCa5ubmhtra2wftisVg2fx6Px8OyZctYomMaxe7ZMQyDZ8+ewcDAgOswmuTu7o7mnpLi8Xjo0aMHpk2bpsComI6EJTuGYSCVSpW6F2afPn2gpaXV5Hoej4c1a9awqYCYJrFkxzAMNDQ0UFlZyXUYTeLxeHB1dW10HZ/Ph5WVFT744AMFR8V0JCzZMQwDHR0dFBQUcB1GswYMGNDolRsRYd26dRAKWRcEpmks2TEMAxsbGyQnJ3MdRrPc3NxknVHq8Pl82NnZYfz48RxFxXQULNkxDAN7e3vcv3+/2U4gXHN3d4dUKq33nlQqxYYNG8Dns68ypnnsup9hGHh4eKCoqAiJiYlwcXFp1T4kEglyc3ORm5uLoqIiSCQSlJaWQiwWQ0NDA2pqalBXV4euri5MTU2hr6//Wvu3sbGBpqYmysvLAQACgQAuLi4YPXp0q+JluhaW7BiGgZubGwwNDREREfHKZFdZWYm4uDjcvn0biYmJuHv3Lh4/foy8vDxIJJIWlykSiWBubg47Ozs4OzvDyckJbm5ucHR0bPThdh6Ph759++LKlSsAXiTXjRs3Ku2D8IxyYVP8MAwDAHj//feRm5uL8+fP13tfKpXi2rVrOHXqFCIjIxEXF4fq6mro6+vLkpSdnR1MTU3Ro0cPGBsbQ19fH3w+H9ra2hAKhaioqEB1dTWqqqrw/PlzPH36FNnZ2cjIyEBSUhLu3r2Le/fuoaamBoaGhhg0aBCGDBmCwMBAWFpaymJZsGABduzYAalUCg8PDzbND9NSbKZyhmFeOHHiBN555x08fPgQffr0QUxMDH766Sf88ccfePr0Kfr06QN/f3/4+fnBz8+vXhKSB7FYjJs3byIqKgoXL17ExYsXUVJSAnd3d4wfPx6TJk3C+fPnERwcDACIiYmBt7e3XGNgOi2W7BiGeUEsFsPCwgKenp5ISUnBnTt30LdvX4wfPx7vvvtuq+/ltVZNTQ3Onz+PY8eO4bfffkNRURH8/f0RERGBt956C2fOnFFoPEyHxiZvZRgGKCsrw44dOyAWi/Hf//4X9vb2+Ouvv3Dr1i0sX75c4YkOAFRVVfH2229j165dyMrKws8//yzrLfrkyROEh4crde9RRrmwKzuG6cKkUil27dqFZcuWoba2FnPmzMH8+fNfu6ekIi1cuBDJyck4ceIEPDw8sH37dnh4eHAdFqPc2JUdw3RV8fHx8PLywty5czF16lSkpKTgq6++UupEBwDr16/HH3/8gRs3bkBDQwNeXl6YPXs2ioqKuA6NUWIs2TFMF0NEWL9+Pby8vKCuro6EhARs2LBB6ZNcnbpHDVxdXXH+/HmEhYXh999/R//+/VnvTKZJLNkxTBdSWFiIt99+G0uXLsXq1asRGRkJJycnrsNqNR6Ph48++gh37tyBs7Mz/Pz8sGHDBq7DYpQQe6icYZRcfHw87OzsoKmp2ab9ZGRkYOTIkSgpKUFMTEynus9lYGCAEydOYNOmTfj888+RkpKCbdu2KfW0RYxisSs7hlFy69atg5WVFXbs2IGamppW7ePRo0fw9vYGn8/HlStXOlWiq8Pj8bBgwQL8+uuv+PHHHzFx4sQGA0czXRfrjckopYKCAhQVFaGoqAiFhYUoLCyU/VxUVISamhqUlJSgpqYG5eXlqKysRFVVFcrLyxtNCHUjeOjo6NQbNJjP50NHRwcAoKWlBXV1dWhra6Nbt27Q0NCAhoYGdHV1Zcs6OjrQ1NSEhoYGtLW10b17d9nn24uTkxOSkpLA5/NhZmaGNWvW4IMPPmjx4MfZ2dnw9fWFgYEBzp49C11d3XaNVxlER0fj7bffxsSJE7Fnzx42pBjDHipnFKu8vBwpKSlISUlBWloacnNz8fTpU+Tl5SEnJwfZ2dnIy8tDbW1tg8/q6upCV1cXenp6UFVVhba2NlRVVaGpqQmRSAR1dXWoq6tDJBI1+Kyqqio0NDQa9NirS5YAUFpaioqKCpSXl6O4uBiVlZWoqKhAYWGhLJk2RlVVFYaGhjA0NISJiQkMDQ1hYGAAIyMjGBsby342NjaGkZHRazVHEhE0NTVlE6vWfWlbW1tj9erVmDBhQrNf5BUVFfD29kZ1dTWio6NhYGDQ4rI7ulOnTmHs2LFYvHgxVq5cyXU4DLdYsmPkr6ysDPfu3UNSUhLu378vS26pqanIy8uTbWdgYAATExOYmprCxMQExsbG6NGjB4yMjGBiYgI9PT1ZctPT0+PwiF6QSqUoLi6WXUmWlJTg2bNnyM/Pl71ycnJk7+Xm5iIvL0+WTOvo6urC0tISVlZWsLKygqWlpexlZWUFU1NTWQLLyMhodFguPp8PqVQKd3d3bNiwAUOGDGk05tmzZ+OXX35BQkICrKys5P9LUXK7du3CJ598gnPnzsHf35/rcBjusGTHtJ5YLEZiYiJu3LiBe/fuITExEffv30daWhoAQE1NDXZ2dujduzd69uyJXr161Xu1tcNFR1FRUYFnz54hOzsbz549Q0ZGBtLT05Geno60tDSkpaXh6dOnshkDVFVVYWFhAUtLS6irq+PUqVNN7lsgEEAikcDf3x8bN26Em5ubbF3dWJfh4eFdenLToKAgXL16FXfu3OkSTbhMo1iyY1pGKpXi/v37uH79Oq5fv464uDjcunULlZWV0NDQgIODAxwdHeHo6AgHBwc4OTmhV69erDdcC4nFYmRlZSE9PR2pqamyZHjnzh3ExcW9sqOFUCiERCLBu+++i9DQUFhZWcHR0RFeXl44ePCggo5CORUWFsLOzg5TpkzB+vXruQ6H4QZLdkzjxGIxbty4IRt9/tKlSygpKYFIJEK/fv3wxhtvyF4ODg4sqbWTefPm4bvvvmtxL8y6ehgwYADi4+ORnJwMCwuL9gyxQ9i2bRs+//xz3L9/v0s25zIs2TH/n1QqxY0bN3Du3DlZcisrK4OJiQn8/PwwePBgDBw4EM7OzlBRUeE63C5jxIgR+Ouvv165nYqKCogIYrEYfD4ffD4f9vb2OHfuHIyMjBQQaUNXr17FyZMn8fXXXwMAli5digkTJsDU1BTGxsYKHcS5pqYGNjY2eO+999jVXdfEkl1XVllZiZiYGJw4cQJHjx5FVlYWjI2NMXjwYPj4+MDX1xdubm6s2zaHzM3NkZWVVe+9uiZLIoKamhocHR3h6ekJV1dX9O/fH3l5eQgMDMS9e/dgb2/PSdzLli3Ds2fPMH/+fNja2gIA8vLycO3aNQQGBgKAwmcsWLlyJXbu3ImMjAx2wtb1sGTX1eTk5ODYsWM4ceIELly4gJqaGnh4eCAgIABjxoxBv379uA6R+f+qqqqgqakJqVQKANDT04ObmxveeOMN9O/fH/3794eNjU2DJuRp06bh/v37nI0TuWzZMty6dQvHjx9vdP3Vq1cxcOBAhSe7tLQ09OrVC2fOnMGIESMUWjbDuXA2XFgXUFRUhN9++w2HDh3ChQsXoK6ujhEjRuDbb7/F6NGjOWvmYppXUlKCr7/+WpbYTE1NW/S56OhofPDBB+0cXeOuXr2Kr7/+GleuXGlyGy8vLwVG9D9WVlawtrbGpUuXWLLrgliy66SkUin++9//4vvvv8fJkyfB4/EwatQoHD58GGPGjGn0wWtGuRgZGWHRokWv9Zlnz57h8ePHGDhwYDtF1byTJ08CAHr37t3sdlw1KHl7ezebiJnOiyW7TiYnJwf79u3D999/j5SUFAwePBg7d+7Eu+++2+7DWjHcS0tLAxHBzs6Ok/LrOqMoa2uBra0tYmJiuA6D4QBLdp1EfHw8Nm7ciPDwcGhra2PSpEmYOXMmHBwcuA6NUaBnz54BALp3785xJMqpe/fuKCgo4DoMhgNs1oMOjIjw559/YujQoXB3d0dSUhL27NmDrKwsbNq0iSW6LqhuDE11dXVOyp81axYAoLi4mJPyX0VLS6vB8G1M18CSXQcklUpx6NAhODs7IzAwECKRCBEREUhISMCkSZPY/bgurG4M0cLCQk7KHzVqFAAgNTWVk/JfpaCgoMPMyM7IF0t2HYhEIsHPP/8MZ2dnBAcHw83NDYmJiTh16hSGDRvGdXiMEqhrvszPz+ek/ICAAAQEBGDnzp1NbpOeno6NGzcqMKr/yc/PZ028XRRLdh0AESE8PBxOTk6YNGkS3njjDSQlJeHAgQNwdHTkOjxGidjY2EAkEiEhIYGzGOqa0mfPno3k5OR669LT0/Gvf/0LwcHBnMQWHx8PFxcXTspmuMWSnZI7f/48BgwYgIkTJ8LDwwP37t3D/v37ZaNSMMzL1NTU4OrqytkD5cCLnpgHDhzAqFGjsGnTJvB4PPB4PAQGBuLs2bPYvn07J701iUj2QDvT9bARVJTUrVu3EBISgrNnz2LkyJFYu3YtG92EaZFly5bhxx9/RGpqKhug+yUXL16Ev78/7ty5A2dnZ67DYRQrnF3ZKZmCggLMnj0b7u7uKCwsxIULF3Dq1CmW6JgWmzp1KrKyslo0gHRXsnfvXnh4eLBE10Up3ZVdbW0tUlNTUVxcjKKiIlRVVaGqqgq6urrQ1dWFjo4OdHR0oK+vD6Gw8zwmKBaL8cMPP2DJkiVQUVHBypUrMWPGDPD5net8pKvWr6L5+/tDTU0NZ8+e5ToUpZCZmQlbW1ts3rwZM2fO5DocRvG4HQhaLBbj+vXriIyMxKVLl/DgwQOkpqa+cqJK4MVsznZ2dnBxcYGvry+GDBnC2QjvbXXt2jXMnDkTDx48wLx587BkyRJoa2tzHVabsfrlTlRUFPz8/HD27Fk2DiReXO1GRkbi/v37UFNT4zocRvG4SXaxsbH44YcfcPjwYRQXF8PU1BT+/v5wcnKCtbU1bGxsoKurCz09PYhEIqipqcmuBIqLi1FcXIyMjAwkJSUhISEBMTExKC0thb29PSZOnIiPP/4YPXr0UPRhvbaysjIsXboU27dvx5AhQ/Ddd9/B2tqa67DajNWvcggMDMSTJ09w/fr1Lv3s5dWrV+Hr64v9+/dzNkA2w7lwkAJFRESQp6cnASAnJyfauHEj3b9/v837FYvFFBUVRfPnzycjIyMSCoU0efJkevz4sRyibh+nTp0iKysr0tXVpV27dpFUKuU6pDZj9atc0tPTSU9Pjz777DOuQ+FMaWkp2djY0FtvvdUp/saYVjuikGSXkZFBb7/9NgGgkSNH0pUrV9qtrKqqKgoLCyMbGxtSU1OjlStXUnV1dbuV97oKCgpo5syZBICCgoIoNzeX65DajNWv8jp06BDxeDw6fPgw16EonEQioXHjxpGJiQnl5ORwHQ7DrfZPdn/88Qd1796dHBwcKDIysr2Lk6mtraWNGzeSpqYmeXh4UGpqqsLKbsqRI0fI0NCQevToQb/99hvX4cgFq1/lN2/ePFJTU6OIiAiuQ1Go2bNnk0gkoqioKK5DYbjXvsnuu+++Ix6PRzNmzKDy8vL2LKpJDx48IGdnZzIxMaFbt25xEkN6ejq9+eabxOfzac6cOVRaWspJHPLG6lc5PX/+nO7cuUMnT56k77//npYvX059+vQhoVBIb7/9NlVWVnIdYruSSqX073//mwQCAR07dozrcDq8R48eUVhYGC1evJiCgoKof//+1Lt3b9LT0yMNDQ3i8/mkp6dHvXv3JldXV/L396eJEyfSV199Rb///jvl5+dzfQhEREfarYPKjh078Nlnn2H16tWvPQGlvJWWluKdd97B7du3ERMTo9C5vo4cOYJZs2bBxMQE+/btw4ABAxRWdnti9cuNoqIipKSkIDMzExkZGXj69CkyMjKQnp6OjIwMZGZmorq6WrZ93eMbYrEYenp6qKiowI8//oiJEydydQjtqqamBlOnTsWRI0fwz3/+E1u3bu10j++0N6lUisjISBw8eBARERHIyMiASCSCra0tbGxsYG1tDT09Pejq6kIkEkEkEqG4uBiFhYUoLi5GSUkJ0tPTce/ePTx58gREBBcXF7zzzjuYOHEiV0Mctk8HlcjISBIKhbRmzZr22H2rVFRUkJeXF/Xp04eKioravbySkhLZvbng4GAqKytr9zIVhdUvd44ePUoACAAJhUJSU1MjgUAge6+xl4qKCrm5udHz589pwYIFxOPxKCQkhGpqarg+HLlKTU0lb29v6tatG3300UckEAiob9++dPz4ca5D6xAqKipow4YN1KtXLwJAAwYMoC+//JKio6NbfV+8sLCQ/vzzT/rss8/IwsKCAJCfnx+dPHlSztG/kvybMZ89e0ampqY0fvx4pev9lJubSyYmJvTRRx+1azlXr14la2trMjQ07HR/aKx+uSWRSMjGxob4fH6zCe7lRPfGG2/UOwHYu3cvaWpqkpeXFz169IjDo5Gf8PBw0tPTIycnJ0pMTCQioqSkJAoKCiIej0cDBgzocvcsW0oqldLevXvJ3NycNDU1acGCBXT37t12Kefs2bM0ZswY4vF45OPjo8hbD/JPdnPmzCETExOlPbv+888/CQBduHBB7vuura2l0NBQUlFRoREjRlBWVpbcy+BaV65fZREWFtaiZKeiokIeHh5UXFzcYB9JSUnUr18/UldXpy+//JKqqqo4OJK2e/LkCY0ZM4YA0MyZM6mioqLBNrdv36agoCACQD4+PqzDykvy8/MpICCAhEIhffLJJ5Sdna2QcmNjY8nb25tUVFTo66+/VsSJs3yT3aNHj0hFRYV27dolz93K3ciRI2ngwIFy3WdKSgr5+vqSSCSizZs3K91Vjzx05fpVJrW1tWRubk48Hq/ZROfp6dlooqtTU1ND69evJy0tLbK2tqYDBw6QWCxW4JG0Xl5eHoWEhJC6ujo5Ojq26OQmJiaG/P39CQANHz6cEhIS2j9QJZaUlETm5uZkZWVFly5dUnj5EomE/u///o9UVVVp7Nix7d1xSr7J7vPPPycrKyul/4OJjo4mAHTt2jW57C88PJy0tbWpf//+7XL5ryy6av0qm0ePHpGvr2+TV3cqKio0YMAAKikpadH+MjIyaPLkySQUCsnOzo727duntD0209PTaeHChaSlpUVGRka0adOm1773+Ndff5G7uzvx+XwKCgqi5OTkdopWed2+fZuMjY3J19eXnj9/zmks0dHRpKenR8OGDWvPFgb5JTuxWEw9evSgZcuWyWuX7crGxoa++OKLNu2jtraW5s+fTzwejz755JMO2xTUEl2xfpXNnTt36MMPPyShUEi9evUiXV3dNie6lz18+JCmTJlCqqqqpK+vT/PmzZPd/+JSTU0NnThxggICAkggEJCJiQl98803bXrcRSqV0vHjx6lv376koqJCwcHB9OTJEzlGrbzy8vLIzMyM/P39labj3M2bN0lXV5fef//99ipCfskuNjaWACjFH0djduzYQUeOHKH4+HgqKSmhuXPnUr9+/Vq9v9zcXBo6dCiJRCLau3evHCNVTl2tfpVJQkICBQcHE5/PJycnJwoLC6Pa2lpat24dCYXCeonOy8urVYnuZTk5ObRmzRpZrzx7e3tasmQJxcXFKeyqvqSkhP744w+aPHky6evrE4/Ho2HDhtGRI0fkOmKORCKhI0eOUJ8+fUhVVZVmzpypsPtWXJBIJDRixAjq1asXFRYWch1OPRERESQQCOi7775rj93LL9lt2bKF9PX1lfZe1ZAhQ+qdAWtra5Oqqip9+OGHtHr1avrll1/oxo0bLfqiiIqKIlNTU7KxsekyDzJ3pfpVFtHR0bLOF/3796ewsLB6yaakpIS6desmewzBx8dHrmfqEomEoqKiaN68eWRlZUUASEdHh0aPHk1r166ls2fPyqUTVm1tLSUlJdGRI0dowYIF5OHhQUKhkPh8Pvn4+NDGjRspJSWl7QfUjJqaGtq1axeZmpqSpqYmhYSEKF0ykIcffviBhEIhxcXFcR1Ko5YsWUJaWlrt0blPfg+VT5kyBTk5OThz5ow8did3ISEh2Lx5M2pqauq9LxQKIRAIUFNTAyJCjx498OTJk0anASEibN26FQsXLsTIkSMRFhYGXV1dRR0Cp7pC/SqLiIgILF++HFeuXIGPjw9CQkIQEBDQ6LYrV67EqlWr4OvrizNnzkBTU7Pd4kpMTMTFixcRFRWFS5cu4enTpwAAfX192NrawsTEBBYWFjAyMoKOjg7U1NSgoaEBNTU1lJaWQiwWo7S0FCUlJcjIyEBubi7S09ORnJyMmpoaCIVCODg4wM/PD4MHD8bgwYNhbGzcbsfTmIqKCmzbtg3r1q0Dj8fD559/js8++wwaGhoKjaM9lJeXw9bWFmPHjsWOHTu4DqdRVVVVcHR0xNChQ7Fnzx557lp+D5WPGDGCpk+fLq/dyd3hw4eb7b0GgHg8XpOX0MXFxTRu3DgSCoW0YcMGpb3CaS+dvX65JpFI6Pjx4+Tu7i7rLXj58uVXfq6goIBGjRrFyRB0z549owsXLtD27dtp3rx5NHHiRBo0aBDZ2tqSiYkJ6enpkaqqKgEgLS0t0tPTI0tLS3J2dqa33nqLJk+eTEuWLKEDBw5QfHy8Ut3zLikpodDQUOrWrRsZGhpSaGioUsXXGt9++y1pamoq/eDze/fuJVVVVXr69Kk8dyu/Zkw3NzcKCQmR1+7k7uHDh6/8IjQzM2v0fsCTJ09k4y8qcrBjZdKZ65dL1dXVFBYWRnZ2dsTn82nMmDF0/fp1rsNi/r/8/HwKCQkhkUhElpaWtGvXLqXvjdwUT09PCg4O5jqMV6qqqiI9PT3avHmzPHd7RG6DxkmlUggEAnntTu769OkDLS2tJtfzeDysWbMGqqqq9d6/fPkyvLy8wOfzcfXqVfj5+bV3qEqps9YvV8rLy7Flyxb06dMHH3/8MTw9PZGUlIQTJ07A3d2d6/CY/8/AwAChoaF4+PAh3n77bXz66adwcXFBeHg4SPHzXrdaamoqYmNjERwczHUojUpJSUFtbS0AQE1NDW+++SZOnz4t1zLkluw0NDRQWVkpr93JHY/Hg6ura6Pr+Hw+rKysGsxi/MMPP2DIkCHw8PBAdHQ0rKysFBGqUuqM9cuF0tJSbNmyBdbW1liyZAnGjRuHR48eYf/+/Z16AOuOztzcHLt27cLDhw8xaNAgvP/+++jXrx/Cw8O5Dq1FLl26BFVVVQwaNIjrUBo1YcIEqKurw9LSEiNGjEBBQQHOnz+P33//HQ8fPpQlwraQW7LT0dFBQUGBvHbXLgYMGNDomT0RYd26dbIR4iUSCb744gvMmDED8+fPx/Hjx9GtWzdFh6tUOlP9ciE/Px8rV66EpaUlli1bhn/84x949OgRtmzZAgsLC87iYl5Pz549sWvXLty6dQv29vZ477334OPjg8jISK5Da9a1a9fg6uoKkUjEdSiNqmvNyMjIwF9//YWoqCgQEd59913Y2tpCXV0dFhYWCAwMrDerx+uQW7KzsbFBcnKyvHbXLtzc3CAWi+u9x+fzYWdnh/HjxwMAysrKMG7cOGzevBk//vgjQkND2RQh6Dz1q2jp6emYO3cuevbsiW+//RZz585Feno6tmzZAhMTE05iYtrOyckJR44cwTYQ3CgAACAASURBVJUrV6Curo4hQ4bgzTffxI0bN7gOrVFpaWmwsbHhOowmubu7g8fjyX6ura2t97cskUiQlZUFCwuLVvekltu3uL29Pe7fv6/U7dju7u6QSqX13pNKpdiwYQP4fD7S0tLg5eWFuLg4XLx4EZMmTeIoUuXTGepXkZ48eYK5c+fC1tYWv//+O9asWYPU1FSsXLmyyzyu0hUMGDAAERERiI6ORnV1NTw8PBAQEIDbt29zHVo9+fn5MDQ05DqMJjV2ovp3KioqWLx4cavLkFu7joeHB4qKipCYmAgXF5dW7UMikSA3Nxe5ubkoKiqCRCKRPZ9T97yOuro6dHV1YWpqCn19/dfav42NDTQ1NVFeXg4AEAgEcHFxwejRo3Hr1i2MGjUKhoaGiI2Nhbm5eauOobPq6PWrKLdv38Y333yDn3/+GVZWVli3bh1mzZql1M/1MW3n6+uLqKgoREREYOHChXB1dcX48eOxdu1a9OnTh+vwUF5e3q7PYLZV3759IRAIIJFIGl0vFAoxd+5cmJmZtboMuSU7Nzc3GBoaIiIi4pVfhpWVlYiLi8Pt27eRmJiIu3fv4vHjx8jLy2vyYBsjEolgbm4OOzs7ODs7w8nJCW5ubnB0dKx3SVyHx+Ohb9++uHLlCoAXX74bN27EhQsXMG7cOLi7u+O3336Djo7O6x18F9CR67exbeUtJiYGoaGhOHnyJFxcXPDDDz/gww8/VOoerIz8DR8+HDdu3MDRo0exZMkSODg4YOrUqVi5ciVMTU05i0tdXR1VVVWclf8qampqsLOzQ1JSUqPrVVRU8J///KdNZcgt2fH5fAwbNgwnTpzA/Pnz662TSqW4du0aTp06hcjISMTFxaG6uhr6+vpwdnaGi4sLJkyYAFNTU/To0QPGxsbQ19cHn8+HtrY2hEIhKioqUF1djaqqKjx//hxPnz5FdnY2MjIykJSUhDNnzmDTpk2oqamBoaEhBg0ahCFDhiAwMBCWlpayWLy8vHDjxg1IpVJ4eHjg+fPnCA4OxpgxY3DgwAGlvYHLtY5av0OHDm3X38ulS5ewbt06/Pnnn/Dx8cEff/yBMWPGKCTBMsqJz+cjKCgIY8eOxb59+/Dll1/i4MGDmDFjBpYsWQIjIyOFx6SpqYnS0lKFl/s6Bg4c2GjPS6FQiIULF7b99ybPp/aOHz9OPB5PNvvxpUuXaPbs2dSjRw8CQH369KHp06fT/v37KS0tTZ5FE9GLMfbi4uJo48aNFBgYSDo6OsTj8eiNN96gtWvXUlZWFh04cED2oPHcuXOJz+fTnDlzSCKRyD2ezqaj1W9MTIzcYyD632gnnp6esglBO9uM9Iz8VFdX065du8jY2Ji0tbUpJCSk2XkG28PUqVNpxIgRCi3zde3YsaPewOZ1Ly0tLXlMQyTf+exqa2vJxMSEAgMDycXFhQBQ3759adWqVXT79m15FtUi1dXVdPr0aZo5cyYZGBiQUCik4cOHEwCytLQkPp9PW7ZsUXhcHVVHqt+33npL7uXVjZDv6OgoG+2ks86Zx8hfaWkphYaGkq6uLhkYGFBoaGijM6s3pqXbNSU0NJQsLS3btI/2dvXq1QaJTigU0tq1a+Wxe/klu9LSUtq8eTMZGBiQSCSioKAg+uuvv+S1+zarrq6mI0eO0LBhw2Sjty9YsKDLjXHZWh2tfm1sbOjIkSNyqd+6Ib1sbGxkc58lJSXJIWqmKyooKKCQkBDS0NAgc3Nz2rVrF9XW1ja5vVQqJR8fHzp16lSryzx16hTxeDzKyclp9T7aW2VlJQkEgnrJTk9PT14zlbQ92UkkEvr222+pe/fu1K1bN1q6dCkVFBTII7h285///IcCAwOJx+ORp6cnxcbGch2S0urK9VuX4M3MzEhVVZWCg4O75KzWTPvIy8ujkJAQUlNTo549ezY57uaxY8cIAKmpqVFUVFSryiorKyM1NTX66aefWvyZ3NxcOnfuHG3dupXmzp1LQUFB5OPjQzY2NmRoaEh6enqkoqJCAEhTU5P09PTIzMyMHB0dafjw4TRp0iRatGgRhYWF0fXr11t0dWpraytLdAKBQJ7jY7Ztip/4+HjMmjULN2/exNy5c7Fo0aLX7i7OBSICj8dDQkICFixYgKioKMycORNr165lz0C9pKvWb0FBAbZt24Zt27ahpqYG06ZNQ0hICHr06KGA6JmuJj09HatXr8bevXthb2+PFStWYMKECeDxeJBKpXB0dMSjR48AvOihHB0d3eTQeM3x9/eHlZUVwsLCGqwjIiQmJiIyMhJRUVGIjo5Gbm4uAKB79+6ws7ODqakpzMzMYGxsDD09PQgEAmhqakJVVRVlZWWora1FZWUlCgsLkZWVJetglpycjKqqKvD5/HpTOPn7+zeYwmnq1Kk4ePAgJBIJDAwMkJaWBnV19Vb8Vhto3RQ/UqmU1q1bRyoqKjR48GClnb26JaRSKR04cIBMTEzIysqq3To1dCRdtX5zc3NpxYoVpKOjQ927d6cVK1Yo/VUs03kkJSVRUFAQ8Xg8GjBgAEVERND+/fvrTV0lFApJV1e3Vc3oW7ZsIS0tLVmzoFgspgsXLtCcOXPIwsKCAJCuri4FBATQhg0bKCIiQi7NnmKxmB48eEC//vorLVy4kAYMGCCbnHfgwIG0fv16evz4MRERbd26lQQCAfH5fNq1a1eby37J6zdjPn/+nEaMGEEqKiq0fv36TnPPKz8/n0aPHk1CoZDWr1/PdTic6Yr1m5KSQnPmzCF1dXUyNjamFStWUFFREUeRMl1dXFwcjRgxQpZ8+Hx+g04bRkZGrz17e0FBAampqdGmTZvoq6++IktLSwJATk5OtGzZMrp+/brCeqWXlpbS8ePHaerUqdS9e3fi8Xjk7+9Pq1atIgDtMR3X6yW79PR0cnJyIgsLi055n0sqldLGjRtJIBDQ7NmzO+y8Va3V1er39u3bFBwcTEKhkHr27EmbN29uc683hpGX+fPnN0h0dS8VFRWysrKi7OzsFu/vwYMH5OHhQUKhkAwMDOg///kP3bt3rx2PoGXEYjGdPn2axo4dK3v04L333pP3hMQtT3YPHz4kc3NzcnFxoczMTHkGoXSOHTtG6urqNGHChGZ7SXUmXa1+RSIRCQQCcnJyooMHD3aZemY6hsrKSjI2Nq7XhNlYwrO3t39lU3taWhp99NFHJBAIyN7ensLCwpR21vXMzEyytbUlLS0tMjQ0pA0bNsjrCq9lye7p06fUu3dv8vT0pMLCQnkUrPSioqJIQ0ODpk2b1mma8prSVetXJBJ1ifplOp4NGzY06IbfVMJzd3dv9CqopqaGQkNDSVNTk2xsbOinn37qEINnFBQUUH5+Pi1atIg0NDTIwcGBzp0719bdvjrZlZeXU79+/cje3p7y8/PbWmCHcvLkSVJRUaEVK1ZwHUq7YfXbueuX6XiKi4tJV1f3lYnu5Xt4Q4cOrXcFdPfuXerbty+pq6vTV199pbRXcq+SkpJCgYGBBIBmzJhB5eXlrd3Vq5PdrFmzSE9Pj1JTU1tbSIe2c+dO4vP5dOHCBa5DaResfjt3/TIdz5EjR8jMzKxeE6aqqmqjQ2m9nPDGjh1LYrGYvv/+e9LQ0KCBAwfKejl2dEePHiV9fX1ydHSkO3futGYXzSe7urEQf/3119ZF2ElMmDCBzM3NO10TH6vfFzpr/TIdW2VlJd2+fZuOHj1KoaGhNH36dPL29qbu3bvLkhyPxyM1NTVZYnRwcCA+n0+LFi3qdPeh09PTydfXl7S1tens2bOv+/GmHyqvqamBo6MjvLy8cPDgwTY9zdfRFRYWws7ODlOmTMH69eu5DkcuWP3+T2esX6ZzKy0txcOHD2Wv+/fv49SpUygqKsKoUaPw559/ch1iu6itrcX06dNx+PBh7Nu3Dx9++GFLP9r0Q+WbNm0idXV1Sk9Pb0sy7jS2bt1KIpGo0zT3sfqtr7PVL9N1SCQSev/996lbt2504cIFKigo6HRXdS+TSqX0+eefk0AgoKNHj7b0Y403Y0okErK0tKQFCxbIL8I2mDVrFkG+sxG9turqarK0tKSFCxdyGoc8cFW/aOYm+zfffEO7d+9WaDwv60z1y3Qtc+bMITU1NTp//jzXoSjUv/71LxKJRBQZGdmSzRtPdmfPniUASvHAYVpamuwL8ebNm5zGsmLFCjI2NqaamhpO46iTlZXVqs9xWb+5ubmy+nzZuXPnCAAdOnRI4THVUbb6ZZhX+fnnn4nH41F4eDjXoSicRCKhCRMmkLGxcUuGNTvCb6xx8/Dhwxg4cCDs7e3b0LoqH+Hh4Th+/DgAIDY2ltNYpk6diry8PFy4cIHTOOqMGzcODg4OWLt2LVJTU1v8OS7rt6nZhutmFP/5558VGU49yla/DNOcjIwMfPrpp5gzZw4mTJjAdTgKx+fzsW/fPujo6GDy5MmgV8xp0Giyi46OxptvvtkuAb6O4uJiFBUVISAgAAAwc+ZMTuOxsrKCtbU1Ll26xGkcdcRiMe7fv4/ly5ejd+/e8PT0xPbt22WjlTdFWeq3MSdOnOCsbGWrX4ZpzieffAIzMzOEhoZyHQpntLS0cODAAURERODQoUPNbtsg2T179gyPHz/GwIED2y3Aljp9+rTsjGX37t0AgFu3bnEZEry9vXHlyhVOY/g7sVgMIsL169cxb948mJqaYuDAgdiyZQsKCgrqbatM9duYV/2HbW/KWL8M83eRkZH4888/8X//938QiURch8MpT09PTJkyBUuWLEFVVVWT2zVIdmlpaSAi2NnZtWuAr1JcXIyLFy+iX79+AF4cEMB9U6atre1rNRkqEhFBIpGAiBAXF4d///vfMDExwahRo7B//36Ul5crTf0CAI/Hq/daunQpRo4cyWlMyly/DFNnxYoVePvtt5W2hUbRVq1ahdzcXPz4449NbiP8+xvPnj0D8GLCPi7duHEDQUFBsp/rkt6JEyfw8ccfcxUWunfvjmfPniE8PJyzGOqUlpY2uU4ikciW//rrL5w5cwazZ8+WXdHp6Oi0e3yv8nIbe15eHrZt24bg4GDs2bOnyXt77a179+4NroYZpj3MnDkTRISpU6fC29u7xZ9LTk5GdHQ0Tp8+3Y7RNcTj8Zpc980338DW1haDBw/m5LvFzMwMQUFB2Lt3L2bNmtXoNg2SXWVlJQDIa3bYVtu8eXOj929OnDiB5ORk2NrachDVizbi8vJy/OMf/+Ck/L/H0hJisRgAUFFRgXPnzgF48ftdtmwZVFRU2i2+12FkZITPPvsMxsbG2LZtG7766itO4tDS0kJZWRm++OILCIVCaGtrA0C9ZRUVFdnv/uVlVVVVaGpqNlhWU1ODhoZGg2Wma8vPz8cff/yBPXv2oGfPnvj4448xadIkmJubN/u5/fv3w9zcHMOHD1dQpC8QEfLy8mSzixcVFckS261bt7Bs2TJ8//33nJ2sTp8+HX5+fkhMTISzs3OD9Q1GULl48SL8/f2Rm5vL2dn11atXkZqaiokTJ9Z7/9atW+jfvz8OHTrUYJ2ibN26FWvXrkV2djYn5b/sjTfewI0bN5rdRiAQgIggFAoREBAAd3d3LF68mNP6rTtDbKz3VHPrFGHr1q1YtWoVevXqhZqaGpSXlwMAqqurUVFR0WC5LUQikeyk8uVldXV12X2Yl5c1NDSgpqYGANDU1ISqqmqDZS0tLdkJzMvL2traEAqFDZa7desGgUDQYFlHRwd8Pr/BMiM/I0eOxJkzZ2Q/C4VCSCQSeHp6Ytq0afjwww9lJ0wvGzhwINzd3bF9+3ZFhivT1N9oXl4eZsyYAQA4cOCAwq/wiAhGRkZYunQp5s6d+/fV4Q2u7OqaL/Pz8zn7MgwLC2u0h1G/fv0QEBCAn3/+mbNkl5+fz3kT76vUfWHxeDwMHz4c77//PsaNGwctLS0kJiZi8eLFnNZvU9LT0wGgyWYIRcjPz4epqSmuX7/+Wp+rrKyU3RyvW27sPXktl5eX49mzZ6/12bKyMtTW1rbit1JfU0la2ZZ1dXWbbXrjWnV1db2f61pgrl+/jri4OMyfPx/jxo3D5MmTMWzYMPB4PFRXVyMhIQH/+te/uAi5WUZGRpg3bx6GDRuGqKgoWS96ReHxePDy8sLly5cbS3YNmzFtbGwgEomQkJAAJycnhQT5ssOHD8PAwKDJs4J+/frh66+/xuHDhzlJePHx8XBxcVF4ua/C4/EgFAohFovh7u6ODz74AB988AEMDQ3rbcd1/ebl5cmWi4uLZfWcnJyMAwcOAADmz5+v8LjqtLZ+1dXVZV+yenp68g5LroqKimRn5S8vFxYWyrapWyYiFBUVNViWSqUoLi4G8OL+cElJSYNlsVgsu6/88nJtbS3KysoaLL98Jf3yclu83Gzclivp9riqbur46u63V1RU4JdffsHBgwfRs2dPTJ48GQMHDkR1dTX69+/f5t9Ne3B3dwcAnDp1SuHJDgD69++PY8eONbqu0YGgvb290b9/f3z77bftHly9YP52FpaWlgZLS8sm1ze2TXsiIhgYGGDFihWYM2eOQspszsvNmK6urpg0aRL+8Y9/oEePHs1+Tlnq92UBAQEICAjAW2+9pbD6/Dtlq1+mvlddvbbnlXRLl1/n6llTU/O1EvrLzYc7d+7EtGnTOLnn/qpbDVzeiti2bRtWr16NnJycv69q2IwJAMOGDcOPP/6Ibdu2yZrEFOFVvxyu7uPUiYqKwvPnz2WjfXDNxcUF77zzDt5//31YW1u3+HPKWr9cU7b6ZerrSFfPxcXFkEqlDZZfvpKeOHEiHj161KL9CQQCSCQSmJmZISsrCwMGDFCazmXKRF9fv14LRT2NDSL2+PFj4vF4dPr06VaMWNZ5BQcHk4eHB9dhtBmr38Z1lvplOgY7O7smB0bn8XikoqJCAMjW1pZWrFhB9+7dk41rW1RUxFncaGRs2zpFRUUEgJYuXargqF747rvvSF9fv7FVjY+N2bt3bwwePBibNm2Se+btqDIzM/Hrr7/Keht1ZKx+G+pM9ct0DH9v7uTxeLKWFhsbGyxevBjJycl48OABVq5cCXt7exgYGAD43/PQyqbutsqQIUM4Kf/Zs2ey31EDTWXIixcvEoDWzAjbKU2ZMoV69uxJVVVVXIciF6x+6+ts9csoP3Nzc+LxeCQQCIjP55OPjw9t37692dlM8vPzicfj0alTpxQYaX1o4souNzeXAgICKCAggIOoXpg8eTINHz68sVWNT/FTJyAggJycnKiysrJ9Iusgrly5QgKBgH766SeuQ5ErVr8vdNb6ZZRbr169aNiwYbR7927Ky8tr8edsbW1p2bJl7RhZ0+qaKfG3ptSbN2/KEl1ubi4nsRERWVtb04oVKxpbdaTR3ph1MjIy0K9fP3z00UfYunWr/K85O4CysjK4ubmhd+/eOH36tFI/t/O6WP127vpllFtZWVmLR0F62fTp03Hv3j1cvny5HaJq2quGC/Px8YGXl5cCI6ovNTUVvXv3xpkzZzBixIi/rw5/5fTfhw4dIh6PR4cPH5ZzDlZ+EomExo0bRyYmJi2ZHLBDYvXbueuX6Xz++9//EgBKSkriOhSlsnz58uYmX26+GbPOvHnzSE1NjSIiIuQbnZKbPXs2iUQiioqK4jqUdsXqt3PXL9O5SCQSsrKyonnz5nEditKorq4mCwsL+vzzz5vapGXJTiKR0Icffkja2tp0/vx5+UWopKRSKf373/8mgUBAx44d4zqcdsfql2G4U1tb+9qf2bJlC4lEIkpLS2uHiDqezZs3k0gkovT09KY2af6e3ctqa2sxadIkHDt2DD/++CNnY1O2t5qaGkyZMgVHjx7Fvn378MEHH3AdkkJ0pfqdOnUqfv311y5Vv4zy2rRpE0JCQqClpQVdXV3o6enBwMAABgYG0NPTa/SlpaWFCRMmwNPTE7/88gvXh8Cp58+fw87ODtOmTcO6deua2uzV9+xeJpFIaMGCBcTj8SgkJKSpttEOKzU1lby9vUldXZ2MjY1p8+bNXaorelep327dutFff/3FdTgMQ0REiYmJjT5YzufzSVVVldTU1EhVVZUEAkGj2w0ePJjKy8u5PgzOjBs3jszNzamwsLC5zVrWjPl3e/fuJU1NTfLy8qJHjx61LkIlEx4eTnp6euTk5ERnzpyh6dOnk4qKCvXq1Yt2795N1dXVXIeoMJ29fhMTE7kOh2HqMTIyanI0laYSoba2Nr355pukp6dHT5484foQOLFjxw4SCAR04cKFV23aumRHRJSUlET9+vUjdXV1+vLLLzvsFdCTJ09ozJgxBIBmzpxJFRUVsnUpKSn0z3/+k1RVVcnS0pJ27NjRYY/zdXWF+mUYZTF16lTZ8GAtSXR+fn6UkZFBFRUV5OrqSra2tq/1rF5ncOLECRIKhbRq1aqWbN76ZEdEVFNTQ+vXryctLS2ytramAwcOkFgsbssuFSYvL49CQkJIXV2dHB0dmz0zSE9Pp08//ZREIhGZmJhQaGgoFRcXKy5YjnSV+mUYLlVXV9OqVauIx+M1m+RUVFRIRUWFQkNDSSKRyD6fnZ1Nffr0IQ8Pj1c15XUakZGRpKGhQTNmzCCpVNqSj7Qt2dXJyMigyZMnk1AoJDs7O9q3b5/SjsqRnp5OCxcuJC0tLTIyMqJNmza1+N7U06dP6fPPP6du3bqRjo4OffHFF13i+ayuUr8MowhisZji4uJo3bp19NZbb5GmpqZs8OemEp1AICB7e3u6detWo/t89OgRWVhYkLOzc3M9EjuFX3/9lUQiEQUFBb3Oybd8kl2dhw8f0pQpU0hVVZX09fVp3rx5SnF/pKamhk6cOEEBAQEkEAjIxMSEvvnmm1bf1C0sLKQ1a9aQsbExiUQimjVrVqe5t9WcrlK/DCNvd+/epW3bttG7775Lenp6BICMjY1p4sSJtHv3bnr06BG5ubk1muT4fD6FhIS8st9ARkYGOTs7k7m5OV29elVBR6Y4UqmU1q9fT3w+nz799NPXbWWSb7Krk5OTQ2vWrKFevXoRALK3t6clS5ZQXFycwprBSkpK6I8//qDJkyeTvr4+8Xg8GjZsGB05ckRunU0qKyvpu+++oz59+hCfz6d3332XIiMj5bJvZdZV6pdhWuvevXu0a9cu+uCDD8jU1JQAkI6ODgUGBtLmzZvpzp07DZrfli9fTqqqqrJEJxQKydzc/LUGPSgsLKSRI0c22tzZkeXl5cmOa+PGja3ZRfskuzoSiYSioqJo3rx5ZGVlJavw0aNH09q1a+ns2bPNjvDdUrW1tZSUlERHjhyhBQsWkIeHBwmFQtlI4hs3bqSUlJS2H1ATxGIxhYeHk4+PDwEgV1dXCgsL6/Rful2lfhmmOVKplG7fvk3btm2joKAgMjY2JgCkpaVFI0aMoLVr19K1a9deeSIYExNTrzlzxowZVFpa2qp4NmzYQCoqKjRo0CC6c+dOaw+Nc1KplPbv30/GxsbUs2dPunLlSmt31fKHyuUhMTERFy9eRFRUFC5duoSnT58CeDG7rK2tLUxMTGBhYQEjIyPo6OhATU0NGhoaUFNTQ2lpKcRiMUpLS1FSUoKMjAzk5uYiPT0dycnJqKmpgVAohIODA/z8/DB48GAMHjwYxsbGijo8AEBcXBw2b96M8PBwdO/eHZ988gn++c9/wsjISKFxcKEr1C/DSCQS3Lp1C1FRUYiMjMSlS5dQUFAAHR0dDBo0SPZ/093dHUKhsMX7FYvF0NfXh6qqKsLCwjB69Og2xZmQkIBZs2YhISEBn332GRYvXozu3bu3aZ+KdOPGDSxYsAAxMTGYOXMm1qxZA11d3dbuLlyhye7vCgoKcOfOHdy9exePHj1CTk4OsrKykJubi5KSElRXV6O8vBw1NTXQ0tKCiooKtLW10a1bN5iZmcHExATm5uawt7eHk5MTHB0doaamxtXh1JOVlYUdO3Zg9+7dKCsrw7hx4zBr1iwMHjyY69AUpjPXL9N1lJWVITY2FjExMbhy5QpiYmJQUlICAwMD+Pr6ws/PD35+fujbt69s8tXW2rlzJ8aPHw9DQ0O5xC6VSrFnzx4sXboUVVVV+Oyzz7BgwQKlTnrXr1/HqlWrcPLkSXh5eWHbtm1wd3dv6265TXZdQWVlJQ4fPoydO3ciNjYWjo6OmDVrFoKDg9tylsIwTDtJT0+vl9hu374NsVgMS0tL+Pr6wtvbG35+fnBycuowU0KVl5djz549WLduHZ4/f47AwEDMnDkTw4cP5zo0AEB1dTWOHz+O3bt349y5c+jbty+WLFmCCRMmyOt3zJKdIsXHx2Pnzp04dOgQpFIpJk6ciJkzZ2LAgAFch8YwXZJYLEZCQgIuX74se2VmZkIoFMLV1RXe3t7w9vaGj48PzMzMuA63zcrLy3Hw4EHs3LkTN2/ehKOjIyZMmIDx48ejb9++Co2luroa586dw9GjR/H777+jtLQU77zzDmbNmoVhw4bJuziW7LhQUlIi+w93584dODg4YNKkSQgODu4Uf1AMo6weP36M2NhYxMbGIi4uDvHx8aisrIS+vj4GDhyIgQMHwtfXFx4eHtDQ0OA63HZ17do1/PTTTzh27BgyMzPRu3dv+Pv7Y/DgwRg0aBB69+4t1/Jqa2sRHx+P6OhoREVF4eLFiygtLcWAAQMwfvx4fPTRRzAxMZFrmS9hyY5rcXFxCAsLw6FDh1BcXIxhw4Zh0qRJGDduHNTV1bkOj2E6rPz8fFlSq0twBQUFEAqFcHFxgaenJzw9PeHl5QUHB4cO0yQpb0SE2NhYnDx5EhcvXkRsbCyqqqqgq6sLJycnODs7w87OTnYP3djYGDo6OlBVVYWmpiZUVVVl997Ly8tRVFSEzMxM5OTkICMjA3fv3sXdu3fx4MED1NbWwtjYGIMGDcKQIUMQGBgIc3NzRRwmS3bKorq6Gn/++SfCwsJw5swZh2trSQAABdFJREFUqKurY8KECXjvvfcwdOjQ1+rVxTBdTUlJCW7evIm4uDjExcXh2rVrSE1NBQBYW1vD09MTHh4e8PT0hKurKzuRbEZ1dTXi4uJw584dWQezx48fIzc3F2KxuMX70dDQgLm5Oezs7ODs7AwXFxe4urrC3t6+HaNvEkt2yigvLw8///wzfvrpJ1y/fh3du3fH2LFjERQUhGHDhrHEx3RpOTk5SEhIwM2bN5GQkICEhAQ8fvwYRARjY2NZUqv7V19fn+uQOwWpVIrc3FxZb+qamhqUlZWhtrZWdoWnpaUl602to6PDdcgvY8lO2aWkpCA8PBzh4eENEt+QIUOgqqrKdYgM0y6ICE+ePEF8fHy9xJaTkwMAsLKygqurK/r37w9XV1e4urrCwsKC46gZJcWSXUfy98SnpaWF4cOHY+TIkRg5ciT7Q2c6rKKiIty9exeJiYlITEzE7du3cfPmTZSUlEAgEMDOzq5BYmNXbMxrYMmuo0pNTcXp06dx6tQpnD9/HhUVFejbt68s8fn4+LDmTkbplJeXIykpCYmJibLkdvfuXWRmZgIAunXrBkdHR/Tt21eW1FxcXDp9z0im3bFk1xlUVVXh4sWLsuT38OFDaGpqwsvLC76+vhg0aBC8vLygqanJdahMF1FRUYHk5OQGiS0lJQVEBHV1dTg4OMh6+zk7O8PJyQlWVlZch850TizZdUaPHj3ChQsXEB0djUuXLiElJQVCoRBubm7w9fWFr68v3Nzc2BcL0yZisRgpKSlITk7GgwcP8PDhQyQnJ+Phw4fIyMgAAKioqMDW1hZOTk5wcXGBo6MjXFxc0Lt37zYPrcUwr4Elu64gKytLlviioqJw9+5dSKVS6Ovrw83NTdZc5OrqCltbW/D5fK5DZpRIVlYWkpOTZYnswYMHSE5ORkpKCmprawEAxsbGsLOzg62tLWxsbGBjYwM7OzvY2NhARUWF4yNgGJbsuqTS0lLcunULCQkJiI+PR0JCApKSklBbWwstLS04OjrC2dm53gDMVlZWXfah284uOzsbaWlpSE1NRWpqqmw5LS0NKSkpqKqqAvDiflpdMrO1tZUlM1tbW3Tr1o3jo2CYZrFkx7xQXV2NxMRExMfHIzExEUlJSUhKSpJN06OpqQkHBwc4ODjAxsYGffr0kb0MDAw4jp5pSm1tLfLy8pCWllYvib38b10yEwqFMDc3h5WVFXr27Cl79e7dG3Z2dmw6JaYjY8mOaV5RUZEs8d27dw9JSUl4/PgxUlNTZU1YOjo6sLa2Rp8+fdCrVy/ZF6a5uTnMzc3lNl0J8z9VVVXIzs7G06dPkZubK5s6KSsrC3l5ecjMzERubi7y8vJQ9ydel8xeTmR1r7r6Yj14mU6KJTumdcRiMTIyMvD48eN6r5SUFGRmZiI/P1+2rbq6OiwsLGBubg4zMzMYGhrCxMQExsbGsmUjIyMYGRl1yfs7YrEYz58/x/Pnz1FYWNhgue7fp0+fIicnB9nZ2SgsLKy3D2NjYxgZGcHMzAzGxsbo0aMHTExMZP9aWFjAzMyMJTOmq2LJjmkflZWVSE9PR2ZmJjIzM5GWlobMzExkZ2cjPz8f2dnZyPt/7d3LioMwAIXhA6YYsTHGjdj3382btYJ3owu1i8FAOwgtFYZxzgdBwUVw9RvBeL26V2grrTWMMZtDKQUpJbTWCMPQna9/PI+iCJ7nQQgBpdTu9zXPM6qqcpve9n2PcRxR1zWmaUJRFO6P68MwwFrrtlTailnTND/m8X0fSZLAGOOOWZYhy7KHiF0uF6Rp+i8fEojewNjR72qaxgXwdrshz3MURbE52raFtRZVVb08x7pv3yfWcL1iDa2UEkEQQCkFIcRDvJ5D9nyNH1ET7Yqxo7+r6zpYa1HXtVs9lWWJZVncygv4Duo7u7VviaIIQgjEcYzT6YTz+YwgCCCldEEzxnw8DxHtjrEjIqLD++LXw0REdHiMHRERHR5jR0REh3cHFkcqrezOhSkAAAAASUVORK5CYII=" alt="Figure 1. Markov model for comparison of HIV therapy. A: 200 &lt; cd4 &lt; 500, B: cd4 &lt; 200, C: AIDS, D: Death." width="443" />
<p class="caption">
Figure 1. Markov model for comparison of HIV therapy. A: 200 &lt; cd4 &lt; 500, B: cd4 &lt; 200, C: AIDS, D: Death.
</p>
</div>
</div>
<div id="model-states" class="section level2">
<h2>Model states</h2>
<p>The states in the model can be tabulated with the function <code>tabulate_states</code>. For the monotherapy model, the states are tabulated below. The cost of each state includes the annual cost of AZT (Zidovudine).</p>
<table style="width:21%;">
<colgroup>
<col width="9%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Name</th>
<th align="right">Cost</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">A</td>
<td align="right">5034</td>
</tr>
<tr class="even">
<td align="left">B</td>
<td align="right">5330</td>
</tr>
<tr class="odd">
<td align="left">C</td>
<td align="right">11285</td>
</tr>
<tr class="even">
<td align="left">D</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div>
<div id="per-cycle-transition-probabilities" class="section level2">
<h2>Per-cycle transition probabilities</h2>
<p>The per-cycle transition probabilities, which are the cells of the Markov transition matrix, can be extracted from the model via the function <code>transition_probability</code>. For the monotherapy model, the transition matrix is shown below. This is consistent with the Table 1 of Chancellor <em>et al</em>.<span class="citation"><sup>2</sup></span></p>
<table style="width:57%;">
<colgroup>
<col width="12%" />
<col width="11%" />
<col width="11%" />
<col width="11%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Â </th>
<th align="center">A</th>
<th align="center">B</th>
<th align="center">C</th>
<th align="center">D</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">A</td>
<td align="center">0.721</td>
<td align="center">0.202</td>
<td align="center">0.067</td>
<td align="center">0.01</td>
</tr>
<tr class="even">
<td align="left">B</td>
<td align="center">0</td>
<td align="center">0.581</td>
<td align="center">0.407</td>
<td align="center">0.012</td>
</tr>
<tr class="odd">
<td align="left">C</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.75</td>
<td align="center">0.25</td>
</tr>
<tr class="even">
<td align="left">D</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="running-the-model" class="section level1">
<h1>Running the model</h1>
<p>Model function <code>cycle</code> applies one cycle of a Markov model to a defined starting population in each state. It returns a table with one row per state, and each row containing several columns, including the population at the end of the state and the cost of occupancy of states, normalized by the number of patients in the cohort, with discounting applied.</p>
<p>Multiple cycles are run by feeding the state populations at the end of one cycle into the next. Function <code>cycles</code> does this and returns a data frame with one row per cycle, and each row containing the state populations and the aggregated cost of occupancy for all states, with discounting applied. This is done below for the first 20 cycles of the model for monotherapy, without half cycle correction, with discount. In addition, the proportion of patients alive at each cycle (the Markov trace) is added to the table. The populations and discounted costs are consistent with Briggs <em>et al</em>, Table 2.3,<span class="citation"><sup>1</sup></span> and the QALY column is consistent with Table 2.4 (without half cycle correction). No discount was applied to the utilities.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a><span class="co"># create starting populations</span></span>
<span id="cb3-2"><a href="#cb3-2" aria-hidden="true" tabindex="-1"></a>N <span class="ot">&lt;-</span> <span class="dv">1000</span></span>
<span id="cb3-3"><a href="#cb3-3" aria-hidden="true" tabindex="-1"></a>populations <span class="ot">&lt;-</span> <span class="fu">c</span>(<span class="at">A =</span> N, <span class="at">B =</span> <span class="dv">0</span>, <span class="at">C =</span> <span class="dv">0</span>, <span class="at">D =</span> <span class="dv">0</span>)</span>
<span id="cb3-4"><a href="#cb3-4" aria-hidden="true" tabindex="-1"></a>mhiv<span class="sc">$</span><span class="fu">set_populations</span>(populations)</span>
<span id="cb3-5"><a href="#cb3-5" aria-hidden="true" tabindex="-1"></a><span class="co"># run 20 cycles</span></span>
<span id="cb3-6"><a href="#cb3-6" aria-hidden="true" tabindex="-1"></a>MT.mono <span class="ot">&lt;-</span> mhiv<span class="sc">$</span><span class="fu">cycles</span>(<span class="at">ncycles=</span><span class="dv">20</span>)</span></code></pre></div>
<table style="width:67%;">
<colgroup>
<col width="11%" />
<col width="9%" />
<col width="8%" />
<col width="8%" />
<col width="8%" />
<col width="9%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="right">Years</th>
<th align="right">A</th>
<th align="right">B</th>
<th align="right">C</th>
<th align="right">D</th>
<th align="right">Cost</th>
<th align="right">QALY</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">0</td>
<td align="right">1000</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">1</td>
<td align="right">721</td>
<td align="right">202</td>
<td align="right">67</td>
<td align="right">10</td>
<td align="right">5153</td>
<td align="right">0.99</td>
</tr>
<tr class="odd">
<td align="right">2</td>
<td align="right">520</td>
<td align="right">263</td>
<td align="right">181</td>
<td align="right">36</td>
<td align="right">5392</td>
<td align="right">0.964</td>
</tr>
<tr class="even">
<td align="right">3</td>
<td align="right">375</td>
<td align="right">258</td>
<td align="right">277</td>
<td align="right">90</td>
<td align="right">5367</td>
<td align="right">0.91</td>
</tr>
<tr class="odd">
<td align="right">4</td>
<td align="right">270</td>
<td align="right">226</td>
<td align="right">338</td>
<td align="right">166</td>
<td align="right">5052</td>
<td align="right">0.834</td>
</tr>
<tr class="even">
<td align="right">5</td>
<td align="right">195</td>
<td align="right">186</td>
<td align="right">363</td>
<td align="right">256</td>
<td align="right">4537</td>
<td align="right">0.744</td>
</tr>
<tr class="odd">
<td align="right">6</td>
<td align="right">140</td>
<td align="right">147</td>
<td align="right">361</td>
<td align="right">351</td>
<td align="right">3925</td>
<td align="right">0.649</td>
</tr>
<tr class="even">
<td align="right">7</td>
<td align="right">101</td>
<td align="right">114</td>
<td align="right">340</td>
<td align="right">445</td>
<td align="right">3296</td>
<td align="right">0.555</td>
</tr>
<tr class="odd">
<td align="right">8</td>
<td align="right">73</td>
<td align="right">87</td>
<td align="right">308</td>
<td align="right">532</td>
<td align="right">2703</td>
<td align="right">0.468</td>
</tr>
<tr class="even">
<td align="right">9</td>
<td align="right">53</td>
<td align="right">65</td>
<td align="right">271</td>
<td align="right">611</td>
<td align="right">2175</td>
<td align="right">0.389</td>
</tr>
<tr class="odd">
<td align="right">10</td>
<td align="right">38</td>
<td align="right">48</td>
<td align="right">234</td>
<td align="right">680</td>
<td align="right">1723</td>
<td align="right">0.32</td>
</tr>
<tr class="even">
<td align="right">11</td>
<td align="right">27</td>
<td align="right">36</td>
<td align="right">197</td>
<td align="right">739</td>
<td align="right">1347</td>
<td align="right">0.261</td>
</tr>
<tr class="odd">
<td align="right">12</td>
<td align="right">20</td>
<td align="right">26</td>
<td align="right">164</td>
<td align="right">789</td>
<td align="right">1042</td>
<td align="right">0.211</td>
</tr>
<tr class="even">
<td align="right">13</td>
<td align="right">14</td>
<td align="right">19</td>
<td align="right">135</td>
<td align="right">831</td>
<td align="right">798</td>
<td align="right">0.169</td>
</tr>
<tr class="odd">
<td align="right">14</td>
<td align="right">10</td>
<td align="right">14</td>
<td align="right">110</td>
<td align="right">865</td>
<td align="right">607</td>
<td align="right">0.135</td>
</tr>
<tr class="even">
<td align="right">15</td>
<td align="right">7</td>
<td align="right">10</td>
<td align="right">89</td>
<td align="right">893</td>
<td align="right">458</td>
<td align="right">0.107</td>
</tr>
<tr class="odd">
<td align="right">16</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">72</td>
<td align="right">916</td>
<td align="right">344</td>
<td align="right">0.084</td>
</tr>
<tr class="even">
<td align="right">17</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">57</td>
<td align="right">934</td>
<td align="right">257</td>
<td align="right">0.066</td>
</tr>
<tr class="odd">
<td align="right">18</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">45</td>
<td align="right">948</td>
<td align="right">191</td>
<td align="right">0.052</td>
</tr>
<tr class="even">
<td align="right">19</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">36</td>
<td align="right">959</td>
<td align="right">142</td>
<td align="right">0.041</td>
</tr>
<tr class="odd">
<td align="right">20</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">28</td>
<td align="right">968</td>
<td align="right">104</td>
<td align="right">0.032</td>
</tr>
</tbody>
</table>
</div>
<div id="model-results" class="section level1">
<h1>Model results</h1>
<div id="monotherapy" class="section level2">
<h2>Monotherapy</h2>
<p>The estimated life years is approximated by summing the proportions of patients left alive at each cycle (Briggs <em>et al</em><span class="citation"><sup>1</sup></span>, Exercise 2.5). This is an approximation because it ignores the population who remain alive after 21 years, and assumes all deaths occurred at the start of each cycle. For monotherapy the expected life gained is 7.979 years at a cost of 44614 GBP.</p>
</div>
<div id="combination-therapy" class="section level2">
<h2>Combination therapy</h2>
<p>For combination therapy, the same model structure was used, and in <code>rdecision</code>, the same nodes, edges and model used for the monotherapy model can be re-used for the combination therapy model by setting costs and transition rates to amended values.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a><span class="co"># set occupancy costs for combination therapy (zidovudine and lamivudine)</span></span>
<span id="cb4-2"><a href="#cb4-2" aria-hidden="true" tabindex="-1"></a>sA<span class="sc">$</span><span class="fu">set_cost</span>(dmca<span class="sc">+</span>ccca<span class="sc">+</span>cAZT<span class="sc">+</span>cLam)</span>
<span id="cb4-3"><a href="#cb4-3" aria-hidden="true" tabindex="-1"></a>sB<span class="sc">$</span><span class="fu">set_cost</span>(dmcb<span class="sc">+</span>cccb<span class="sc">+</span>cAZT<span class="sc">+</span>cLam)</span>
<span id="cb4-4"><a href="#cb4-4" aria-hidden="true" tabindex="-1"></a>sC<span class="sc">$</span><span class="fu">set_cost</span>(dmcc<span class="sc">+</span>cccc<span class="sc">+</span>cAZT<span class="sc">+</span>cLam)</span>
<span id="cb4-5"><a href="#cb4-5" aria-hidden="true" tabindex="-1"></a><span class="co"># modify transition rates by the treatment effect</span></span>
<span id="cb4-6"><a href="#cb4-6" aria-hidden="true" tabindex="-1"></a>tAB<span class="sc">$</span><span class="fu">set_rate</span>(trAB<span class="sc">*</span>RR)</span>
<span id="cb4-7"><a href="#cb4-7" aria-hidden="true" tabindex="-1"></a>tAC<span class="sc">$</span><span class="fu">set_rate</span>(trAC<span class="sc">*</span>RR)</span>
<span id="cb4-8"><a href="#cb4-8" aria-hidden="true" tabindex="-1"></a>tAD<span class="sc">$</span><span class="fu">set_rate</span>(trAD<span class="sc">*</span>RR)</span>
<span id="cb4-9"><a href="#cb4-9" aria-hidden="true" tabindex="-1"></a>tBC<span class="sc">$</span><span class="fu">set_rate</span>(trBC<span class="sc">*</span>RR)</span>
<span id="cb4-10"><a href="#cb4-10" aria-hidden="true" tabindex="-1"></a>tBD<span class="sc">$</span><span class="fu">set_rate</span>(trBD<span class="sc">*</span>RR)</span>
<span id="cb4-11"><a href="#cb4-11" aria-hidden="true" tabindex="-1"></a>tCD<span class="sc">$</span><span class="fu">set_rate</span>(trCD<span class="sc">*</span>RR)</span></code></pre></div>
<p>In this model, lamivudine is given for the first 2 years, with the treatment effect assumed to persist for the same period. The state populations and cycle numbers are retained by the model between calls to <code>cycle</code> or <code>cycles</code> making it easy to change probabilities or costs during a simulation. The cycle count and elapsed time are reset when a new population is set.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a><span class="co"># run combination therapy model for 2 years</span></span>
<span id="cb5-2"><a href="#cb5-2" aria-hidden="true" tabindex="-1"></a>populations <span class="ot">&lt;-</span> <span class="fu">c</span>(<span class="st">&#39;A&#39;</span><span class="ot">=</span>N, <span class="st">&#39;B&#39;</span><span class="ot">=</span><span class="dv">0</span>, <span class="st">&#39;C&#39;</span><span class="ot">=</span><span class="dv">0</span>, <span class="st">&#39;D&#39;</span><span class="ot">=</span><span class="dv">0</span>)</span>
<span id="cb5-3"><a href="#cb5-3" aria-hidden="true" tabindex="-1"></a>mhiv<span class="sc">$</span><span class="fu">set_populations</span>(populations)</span>
<span id="cb5-4"><a href="#cb5-4" aria-hidden="true" tabindex="-1"></a><span class="co"># run 2 cycles</span></span>
<span id="cb5-5"><a href="#cb5-5" aria-hidden="true" tabindex="-1"></a>MT.comb <span class="ot">&lt;-</span> mhiv<span class="sc">$</span><span class="fu">cycles</span>(<span class="dv">2</span>)</span>
<span id="cb5-6"><a href="#cb5-6" aria-hidden="true" tabindex="-1"></a><span class="co"># revise costs and transitions, </span></span>
<span id="cb5-7"><a href="#cb5-7" aria-hidden="true" tabindex="-1"></a>sA<span class="sc">$</span><span class="fu">set_cost</span>(dmca<span class="sc">+</span>ccca<span class="sc">+</span>cAZT)</span>
<span id="cb5-8"><a href="#cb5-8" aria-hidden="true" tabindex="-1"></a>sB<span class="sc">$</span><span class="fu">set_cost</span>(dmcb<span class="sc">+</span>cccb<span class="sc">+</span>cAZT)</span>
<span id="cb5-9"><a href="#cb5-9" aria-hidden="true" tabindex="-1"></a>sC<span class="sc">$</span><span class="fu">set_cost</span>(dmcc<span class="sc">+</span>cccc<span class="sc">+</span>cAZT)</span>
<span id="cb5-10"><a href="#cb5-10" aria-hidden="true" tabindex="-1"></a>tAB<span class="sc">$</span><span class="fu">set_rate</span>(trAB)</span>
<span id="cb5-11"><a href="#cb5-11" aria-hidden="true" tabindex="-1"></a>tAC<span class="sc">$</span><span class="fu">set_rate</span>(trAC)</span>
<span id="cb5-12"><a href="#cb5-12" aria-hidden="true" tabindex="-1"></a>tAD<span class="sc">$</span><span class="fu">set_rate</span>(trAD)</span>
<span id="cb5-13"><a href="#cb5-13" aria-hidden="true" tabindex="-1"></a>tBC<span class="sc">$</span><span class="fu">set_rate</span>(trBC)</span>
<span id="cb5-14"><a href="#cb5-14" aria-hidden="true" tabindex="-1"></a>tBD<span class="sc">$</span><span class="fu">set_rate</span>(trBD)</span>
<span id="cb5-15"><a href="#cb5-15" aria-hidden="true" tabindex="-1"></a>tCD<span class="sc">$</span><span class="fu">set_rate</span>(trCD)</span>
<span id="cb5-16"><a href="#cb5-16" aria-hidden="true" tabindex="-1"></a><span class="co"># and run model for next 18 years</span></span>
<span id="cb5-17"><a href="#cb5-17" aria-hidden="true" tabindex="-1"></a>MT.comb <span class="ot">&lt;-</span> <span class="fu">rbind</span>(MT.comb, mhiv<span class="sc">$</span><span class="fu">cycles</span>(<span class="at">ncycles=</span><span class="dv">18</span>))</span></code></pre></div>
<p>The Markov trace for combination therapy is as follows:</p>
<table style="width:67%;">
<colgroup>
<col width="11%" />
<col width="9%" />
<col width="8%" />
<col width="8%" />
<col width="8%" />
<col width="9%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="right">Years</th>
<th align="right">A</th>
<th align="right">B</th>
<th align="right">C</th>
<th align="right">D</th>
<th align="right">Cost</th>
<th align="right">QALY</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">0</td>
<td align="right">1000</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="right">1</td>
<td align="right">852</td>
<td align="right">109</td>
<td align="right">35</td>
<td align="right">5</td>
<td align="right">6918</td>
<td align="right">0.995</td>
</tr>
<tr class="odd">
<td align="right">2</td>
<td align="right">725</td>
<td align="right">175</td>
<td align="right">85</td>
<td align="right">15</td>
<td align="right">6762</td>
<td align="right">0.985</td>
</tr>
<tr class="even">
<td align="right">3</td>
<td align="right">523</td>
<td align="right">248</td>
<td align="right">183</td>
<td align="right">45</td>
<td align="right">5059</td>
<td align="right">0.955</td>
</tr>
<tr class="odd">
<td align="right">4</td>
<td align="right">377</td>
<td align="right">250</td>
<td align="right">274</td>
<td align="right">99</td>
<td align="right">5004</td>
<td align="right">0.901</td>
</tr>
<tr class="even">
<td align="right">5</td>
<td align="right">272</td>
<td align="right">221</td>
<td align="right">332</td>
<td align="right">175</td>
<td align="right">4705</td>
<td align="right">0.825</td>
</tr>
<tr class="odd">
<td align="right">6</td>
<td align="right">196</td>
<td align="right">184</td>
<td align="right">357</td>
<td align="right">263</td>
<td align="right">4229</td>
<td align="right">0.737</td>
</tr>
<tr class="even">
<td align="right">7</td>
<td align="right">141</td>
<td align="right">146</td>
<td align="right">356</td>
<td align="right">357</td>
<td align="right">3662</td>
<td align="right">0.643</td>
</tr>
<tr class="odd">
<td align="right">8</td>
<td align="right">102</td>
<td align="right">114</td>
<td align="right">336</td>
<td align="right">449</td>
<td align="right">3080</td>
<td align="right">0.551</td>
</tr>
<tr class="even">
<td align="right">9</td>
<td align="right">73</td>
<td align="right">87</td>
<td align="right">305</td>
<td align="right">535</td>
<td align="right">2529</td>
<td align="right">0.465</td>
</tr>
<tr class="odd">
<td align="right">10</td>
<td align="right">53</td>
<td align="right">65</td>
<td align="right">269</td>
<td align="right">613</td>
<td align="right">2037</td>
<td align="right">0.387</td>
</tr>
<tr class="even">
<td align="right">11</td>
<td align="right">38</td>
<td align="right">49</td>
<td align="right">232</td>
<td align="right">682</td>
<td align="right">1615</td>
<td align="right">0.318</td>
</tr>
<tr class="odd">
<td align="right">12</td>
<td align="right">28</td>
<td align="right">36</td>
<td align="right">196</td>
<td align="right">740</td>
<td align="right">1264</td>
<td align="right">0.26</td>
</tr>
<tr class="even">
<td align="right">13</td>
<td align="right">20</td>
<td align="right">26</td>
<td align="right">164</td>
<td align="right">790</td>
<td align="right">978</td>
<td align="right">0.21</td>
</tr>
<tr class="odd">
<td align="right">14</td>
<td align="right">14</td>
<td align="right">19</td>
<td align="right">135</td>
<td align="right">832</td>
<td align="right">750</td>
<td align="right">0.168</td>
</tr>
<tr class="even">
<td align="right">15</td>
<td align="right">10</td>
<td align="right">14</td>
<td align="right">110</td>
<td align="right">866</td>
<td align="right">571</td>
<td align="right">0.134</td>
</tr>
<tr class="odd">
<td align="right">16</td>
<td align="right">7</td>
<td align="right">10</td>
<td align="right">89</td>
<td align="right">893</td>
<td align="right">431</td>
<td align="right">0.107</td>
</tr>
<tr class="even">
<td align="right">17</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">71</td>
<td align="right">916</td>
<td align="right">324</td>
<td align="right">0.084</td>
</tr>
<tr class="odd">
<td align="right">18</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">57</td>
<td align="right">934</td>
<td align="right">242</td>
<td align="right">0.066</td>
</tr>
<tr class="even">
<td align="right">19</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">45</td>
<td align="right">948</td>
<td align="right">180</td>
<td align="right">0.052</td>
</tr>
<tr class="odd">
<td align="right">20</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">36</td>
<td align="right">959</td>
<td align="right">133</td>
<td align="right">0.041</td>
</tr>
</tbody>
</table>
</div>
<div id="comparison-of-treatments" class="section level2">
<h2>Comparison of treatments</h2>
<p>The ICER is calculated by running both models and calculating the incremental cost per life year gained. Over the 20 year time horizon, the expected life years gained for monotherapy was 7.979 years at a total cost per patient of 44,614 GBP. The expected life years gained with combination therapy for two years was 8.884 at a total cost per patient of 50,472 GBP. The incremental change in life years was 0.905 years at an incremental cost of 5,859 GBP, giving an ICER of 6474.44 GBP/QALY. This is consistent with the result obtained by Briggs <em>et al</em>,<span class="citation"><sup>1</sup></span> within rounding error.</p>
</div>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="unnumbered">References</h1>
<div id="refs" class="references csl-bib-body">
<div id="ref-briggs2006" class="csl-entry">
<div class="csl-left-margin">1 </div><div class="csl-right-inline">Briggs A, Claxton K, Sculpher M. <em>Decision modelling for health economic evaluation</em>. <span>Oxford, UK</span>: <span>Oxford University Press</span>; 2006.</div>
</div>
<div id="ref-chancellor1997" class="csl-entry">
<div class="csl-left-margin">2 </div><div class="csl-right-inline">Chancellor JV, Hill AM, Sabin CA, Simpson KN, Youle M. Modelling the cost effectiveness of <span>Lamivudine</span>/<span>Zidovudine</span> combination therapy in <span>HIV</span> infection. <em>Pharmacoeconomics</em> 1997;<strong>12</strong>:54â66.</div>
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
